NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|616688420|gb|KAE86041|]
View 

hypothetical protein W632_01518 [Staphylococcus aureus VET0402R]

Protein Classification

oleate hydratase( domain architecture ID 10014518)

oleate hydratase is a FAD-containing double bond hydratase that catalyzes the hydration of oleate at its cis-9-double bond to form 10-hydroxyoctadecanoate

CATH:  3.50.50.60
PubMed:  19465645

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
PRK13977 PRK13977
myosin-cross-reactive antigen; Provisional
1-591 0e+00

myosin-cross-reactive antigen; Provisional


:

Pssm-ID: 237575  Cd Length: 576  Bit Score: 1097.57  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420   1 MYYSYGNYEAFARPKKPENVENKSAYLIGSGLASLAAACFLIRDGQMEGSKIHILEELPKAGGSLDGENMPLKGYVVRGG 80
Cdd:PRK13977   1 MYYSNGNYEAFARPRKPEGVDNKKAYIIGSGLASLAAAVFLIRDGQMPGENITILEELDVPGGSLDGAGNPEKGYVARGG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420  81 REMENHFECLWDLFRSIPSLEIDHASVLDEFYWLNKEDPNYSRCRVIEKQGQRLVTDgDFTLTKTAIKEILDLCLTNEED 160
Cdd:PRK13977  81 REMENHFECLWDLFRSIPSLEDPGASVLDEFYWFNKDDPNYSKARLIHKRGEILDTD-KFGLSKKDRKELLKLLLTPEEK 159
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 161 LDDVKITDVFSDDFFNSNFWIYWKTMFAFEPWHSAMEMRRYLMRFVHHIGGLADFSALKFTKYNQYESLVLPMVEYLKSH 240
Cdd:PRK13977 160 LDDKTIEDWFSPEFFETNFWYYWRTMFAFEKWHSALEMRRYMHRFIHHIGGLPDLSGLKFTKYNQYESLVLPLIKYLEDH 239
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 241 GVQFEYDVKVEDIKVDVTTSQKIAREILIDRNGNAESIKLTINDLVFVTNGSITESSTYGDNDTPAPPTDELGGSWTLWK 320
Cdd:PRK13977 240 GVDFQYGTKVTDIDFDITGGKKTATAIHLTRNGKEETIDLTEDDLVFVTNGSITESSTYGDMDTPAPLNRELGGSWTLWK 319
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 321 NLARQSPEFGNPDKFCQNIPKKSWfVSATSTTNNKDIIDTIESICKRDPLAGKTVTGGIITINDSAWQISFTINRQQQFK 400
Cdd:PRK13977 320 NIAAQSPEFGNPDKFCGDIPESNW-ESFTVTTKDPKILPYIERITGRDPGSGKTVTGGIVTFKDSNWLMSITVNRQPHFK 398
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 401 DQPKNEISTWIYALYSDVNGNYIKKPITECSGNEICQEWLYHLGVPTDKIEDLAKHASNTIPVYMPYITSYFMTRAIGDR 480
Cdd:PRK13977 399 NQPKNETVVWGYGLYPDRPGNYVKKPMRECTGEEILQELLYHLGVPEDKIEELAADSANTIPVMMPYITSQFMPRAKGDR 478
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 481 PLVVPHQSQNLAFIGNFAETERDTVFTTEYSVRTAMEAVYQLLNIDRGIPEVINSTFDLRVLMDAVYELNDHqdlreitk 560
Cdd:PRK13977 479 PLVVPEGSTNLAFIGQFAETPRDTVFTTEYSVRTAMEAVYTLLGVDRGVPEVFPSQYDIRVLLKATYKLNDG-------- 550
                        570       580       590
                 ....*....|....*....|....*....|.
gi 616688420 561 dskmqKLALAGFLKKIKGTYIESLLKEHKLL 591
Cdd:PRK13977 551 -----KLLLKEGLKKIKGTYIEELLKEYGLI 576
 
Name Accession Description Interval E-value
PRK13977 PRK13977
myosin-cross-reactive antigen; Provisional
1-591 0e+00

myosin-cross-reactive antigen; Provisional


Pssm-ID: 237575  Cd Length: 576  Bit Score: 1097.57  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420   1 MYYSYGNYEAFARPKKPENVENKSAYLIGSGLASLAAACFLIRDGQMEGSKIHILEELPKAGGSLDGENMPLKGYVVRGG 80
Cdd:PRK13977   1 MYYSNGNYEAFARPRKPEGVDNKKAYIIGSGLASLAAAVFLIRDGQMPGENITILEELDVPGGSLDGAGNPEKGYVARGG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420  81 REMENHFECLWDLFRSIPSLEIDHASVLDEFYWLNKEDPNYSRCRVIEKQGQRLVTDgDFTLTKTAIKEILDLCLTNEED 160
Cdd:PRK13977  81 REMENHFECLWDLFRSIPSLEDPGASVLDEFYWFNKDDPNYSKARLIHKRGEILDTD-KFGLSKKDRKELLKLLLTPEEK 159
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 161 LDDVKITDVFSDDFFNSNFWIYWKTMFAFEPWHSAMEMRRYLMRFVHHIGGLADFSALKFTKYNQYESLVLPMVEYLKSH 240
Cdd:PRK13977 160 LDDKTIEDWFSPEFFETNFWYYWRTMFAFEKWHSALEMRRYMHRFIHHIGGLPDLSGLKFTKYNQYESLVLPLIKYLEDH 239
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 241 GVQFEYDVKVEDIKVDVTTSQKIAREILIDRNGNAESIKLTINDLVFVTNGSITESSTYGDNDTPAPPTDELGGSWTLWK 320
Cdd:PRK13977 240 GVDFQYGTKVTDIDFDITGGKKTATAIHLTRNGKEETIDLTEDDLVFVTNGSITESSTYGDMDTPAPLNRELGGSWTLWK 319
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 321 NLARQSPEFGNPDKFCQNIPKKSWfVSATSTTNNKDIIDTIESICKRDPLAGKTVTGGIITINDSAWQISFTINRQQQFK 400
Cdd:PRK13977 320 NIAAQSPEFGNPDKFCGDIPESNW-ESFTVTTKDPKILPYIERITGRDPGSGKTVTGGIVTFKDSNWLMSITVNRQPHFK 398
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 401 DQPKNEISTWIYALYSDVNGNYIKKPITECSGNEICQEWLYHLGVPTDKIEDLAKHASNTIPVYMPYITSYFMTRAIGDR 480
Cdd:PRK13977 399 NQPKNETVVWGYGLYPDRPGNYVKKPMRECTGEEILQELLYHLGVPEDKIEELAADSANTIPVMMPYITSQFMPRAKGDR 478
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 481 PLVVPHQSQNLAFIGNFAETERDTVFTTEYSVRTAMEAVYQLLNIDRGIPEVINSTFDLRVLMDAVYELNDHqdlreitk 560
Cdd:PRK13977 479 PLVVPEGSTNLAFIGQFAETPRDTVFTTEYSVRTAMEAVYTLLGVDRGVPEVFPSQYDIRVLLKATYKLNDG-------- 550
                        570       580       590
                 ....*....|....*....|....*....|.
gi 616688420 561 dskmqKLALAGFLKKIKGTYIESLLKEHKLL 591
Cdd:PRK13977 551 -----KLLLKEGLKKIKGTYIEELLKEYGLI 576
COG4716 COG4716
Myosin-crossreactive antigen (function unknown) [Function unknown];
1-591 0e+00

Myosin-crossreactive antigen (function unknown) [Function unknown];


Pssm-ID: 443751  Cd Length: 578  Bit Score: 1096.42  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420   1 MYYSYGNYEAFARPKKPENVENKSAYLIGSGLASLAAACFLIRDGQMEGSKIHILEELPKAGGSLDGENMPLKGYVVRGG 80
Cdd:COG4716    1 MYYSNGNYEAFARPRKPEGVDDKSAYLVGSGLASLAAAAFLIRDGQMPGENIHILEELDLPGGSLDGAGDPEKGYVIRGG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420  81 REMENHFECLWDLFRSIPSLEIDHASVLDEFYWLNKEDPNYSRCRVIEKQGQRLvTDGDFTLTKTAIKEILDLCLTNEED 160
Cdd:COG4716   81 REMENHFECLWDLFRSIPSLEDPGASVLDEFYWLNKDDPNYSKARLIHNQGEIL-DDGKFGLSKKARLEILKLFLTPEED 159
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 161 LDDVKITDVFSDDFFNSNFWIYWKTMFAFEPWHSAMEMRRYLMRFVHHIGGLADFSALKFTKYNQYESLVLPMVEYLKSH 240
Cdd:COG4716  160 LDDKTIEDVFSEEFFESNFWLYWRTMFAFENWHSALEMKRYLHRFIHHIGGLPDLSALKFTKYNQYDSLVLPLVRWLKDH 239
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 241 GVQFEYDVKVEDIKVDVTTSQKIAREILIDRNGNAESIKLTINDLVFVTNGSITESSTYGDNDTPAP-PTDELGGSWTLW 319
Cdd:COG4716  240 GVDFQYGTKVTDVDFDISGGKKTATAIHLERDGKEETIDLTENDLVFVTNGSMTESSTYGDMDTPAPlNTDGPGGSWELW 319
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 320 KNLARQSPEFGNPDKFCQNIPKKSWfVSATSTTNNKDIIDTIESICKRDPLAGKTVTGGIITINDSAWQISFTINRQQQF 399
Cdd:COG4716  320 KNIAAKDPEFGRPEKFCGNIEESNW-ESATVTTLDDKILPYIEKITGRDPYSGKVVTGGIVTFKDSNWLLSWTVNRQPHF 398
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 400 KDQPKNEISTWIYALYSDVNGNYIKKPITECSGNEICQEWLYHLGVPtDKIEDLAKHASNTIPVYMPYITSYFMTRAIGD 479
Cdd:COG4716  399 KNQPDDVLVVWGYGLFSDKPGNYVKKPMRECTGEEILTELLYHLGVP-DQIEELAANSANTIPCMMPYITAQFMPRAAGD 477
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 480 RPLVVPHQSQNLAFIGNFAETERDTVFTTEYSVRTAMEAVYQLLNIDRGIPEVINSTFDLRVLMDAVYELNDHQDLREIT 559
Cdd:COG4716  478 RPLVVPEGSVNLAFIGQFAETPRDTVFTTEYSVRTAMEAVYTLLGVDRGVPEVFPSQYDIRVLLKATYALNDGKKLPGEG 557
                        570       580       590
                 ....*....|....*....|....*....|..
gi 616688420 560 KdskmqklalagFLKKIKGTYIESLLKEHKLL 591
Cdd:COG4716  558 L-----------LLKKLKGTYIEELLKEYKLI 578
MCRA pfam06100
MCRA family; The MCRA (myosin-cross-reactive antigen) family of proteins were thought to have ...
23-520 0e+00

MCRA family; The MCRA (myosin-cross-reactive antigen) family of proteins were thought to have structural features in common with the beta chain of the class II antigens, as well as myosin, and may play an important role in the pathogenesis. More recent work shows that these proteins act as hydratase enzymes that convert linoleic acid and oleic acid to their respective 10-hydroxy derivatives. It has been suggested that MCRA proteins catalyze the first step in conjugated linoleic acid production. Proteins in this family act in an FAD dependent manner. The structure of a fatty acid double-bond hydratase from Lactobacillus acidophilus has been recently solved showing four structural domains.


Pssm-ID: 428767  Cd Length: 492  Bit Score: 901.07  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420   23 KSAYLIGSGLASLAAACFLIRDGQMEGSKIHILEELPKAGGSLDGENMPLKGYVVRGGREMENHFECLWDLFRSIPSLEI 102
Cdd:pfam06100   1 KKAYIVGSGIASLAAAVFLIRDAQMPGENIHILEELDVAGGSLDGAGDPEKGYVIRGGREMEFHYECLWDLLSSIPSLED 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420  103 DHASVLDEFYWLNKEDPNYSRCRVIEKQGQRLVTDGDFTLTKTAIKEILDLCLTNEEDLDDVKITDVFSDDFFNSNFWIY 182
Cdd:pfam06100  81 PGASVLDEIYWFNKRDPNYSKTRLIDNRGLEIVDDSKLGLSKKDRLELIKLFLTPEEELGDKRIEDVFSPSFFETNFWLM 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420  183 WKTMFAFEPWHSAMEMRRYLMRFVHHIGGLADFSALKFTKYNQYESLVLPMVEYLKSHGVQFEYDVKVEDIKVDVTTSQK 262
Cdd:pfam06100 161 WSTMFAFQPWHSAVEFRRYLHRFIHEIPGLNDLSGLDRTKYNQYESIILPLVKYLKDQGVDFRFNTKVTDIDFDPTGDKK 240
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420  263 IAREILIDRNGNAESIKLTINDLVFVTNGSITESSTYGDNDTPAPP-TDELGGSWTLWKNLARQSPEFGNPDKFCQNIPK 341
Cdd:pfam06100 241 TVTGIHLTQDGEEETIDLGPDDLVFVTNGSMTEGSSYGDNDTPPPLnTDELGGSWSLWKKLAAKSPDFGNPEKFCTDIPE 320
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420  342 KSWfVSATSTTNNKDIIDTIESICKRDPLagktvTGGIITINDSAWQISFTINRQQQFKDQPKNEISTWIYALYSDVNGN 421
Cdd:pfam06100 321 SKW-ESFTVTTKDPKFFDYIEKLTGNDPG-----TGGLVTFKDSNWLLSITVPRQPHFPDQPEDVTVFWGYGLFPDKEGD 394
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420  422 YIKKPITECSGNEICQEWLYHLGVPTDKIEDLAKHaSNTIPVYMPYITSYFMTRAIGDRPLVVPHQSQNLAFIGNFAETE 501
Cdd:pfam06100 395 YVKKPMLECTGEEILTELLYHLGFPEDQIEEILAN-SNTIPCMMPYITAQFMPRAKGDRPEVVPEGSTNLAFIGQFVEIP 473
                         490
                  ....*....|....*....
gi 616688420  502 RDTVFTTEYSVRTAMEAVY 520
Cdd:pfam06100 474 RDTVFTVEYSVRTAQEAVY 492
 
Name Accession Description Interval E-value
PRK13977 PRK13977
myosin-cross-reactive antigen; Provisional
1-591 0e+00

myosin-cross-reactive antigen; Provisional


Pssm-ID: 237575  Cd Length: 576  Bit Score: 1097.57  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420   1 MYYSYGNYEAFARPKKPENVENKSAYLIGSGLASLAAACFLIRDGQMEGSKIHILEELPKAGGSLDGENMPLKGYVVRGG 80
Cdd:PRK13977   1 MYYSNGNYEAFARPRKPEGVDNKKAYIIGSGLASLAAAVFLIRDGQMPGENITILEELDVPGGSLDGAGNPEKGYVARGG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420  81 REMENHFECLWDLFRSIPSLEIDHASVLDEFYWLNKEDPNYSRCRVIEKQGQRLVTDgDFTLTKTAIKEILDLCLTNEED 160
Cdd:PRK13977  81 REMENHFECLWDLFRSIPSLEDPGASVLDEFYWFNKDDPNYSKARLIHKRGEILDTD-KFGLSKKDRKELLKLLLTPEEK 159
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 161 LDDVKITDVFSDDFFNSNFWIYWKTMFAFEPWHSAMEMRRYLMRFVHHIGGLADFSALKFTKYNQYESLVLPMVEYLKSH 240
Cdd:PRK13977 160 LDDKTIEDWFSPEFFETNFWYYWRTMFAFEKWHSALEMRRYMHRFIHHIGGLPDLSGLKFTKYNQYESLVLPLIKYLEDH 239
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 241 GVQFEYDVKVEDIKVDVTTSQKIAREILIDRNGNAESIKLTINDLVFVTNGSITESSTYGDNDTPAPPTDELGGSWTLWK 320
Cdd:PRK13977 240 GVDFQYGTKVTDIDFDITGGKKTATAIHLTRNGKEETIDLTEDDLVFVTNGSITESSTYGDMDTPAPLNRELGGSWTLWK 319
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 321 NLARQSPEFGNPDKFCQNIPKKSWfVSATSTTNNKDIIDTIESICKRDPLAGKTVTGGIITINDSAWQISFTINRQQQFK 400
Cdd:PRK13977 320 NIAAQSPEFGNPDKFCGDIPESNW-ESFTVTTKDPKILPYIERITGRDPGSGKTVTGGIVTFKDSNWLMSITVNRQPHFK 398
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 401 DQPKNEISTWIYALYSDVNGNYIKKPITECSGNEICQEWLYHLGVPTDKIEDLAKHASNTIPVYMPYITSYFMTRAIGDR 480
Cdd:PRK13977 399 NQPKNETVVWGYGLYPDRPGNYVKKPMRECTGEEILQELLYHLGVPEDKIEELAADSANTIPVMMPYITSQFMPRAKGDR 478
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 481 PLVVPHQSQNLAFIGNFAETERDTVFTTEYSVRTAMEAVYQLLNIDRGIPEVINSTFDLRVLMDAVYELNDHqdlreitk 560
Cdd:PRK13977 479 PLVVPEGSTNLAFIGQFAETPRDTVFTTEYSVRTAMEAVYTLLGVDRGVPEVFPSQYDIRVLLKATYKLNDG-------- 550
                        570       580       590
                 ....*....|....*....|....*....|.
gi 616688420 561 dskmqKLALAGFLKKIKGTYIESLLKEHKLL 591
Cdd:PRK13977 551 -----KLLLKEGLKKIKGTYIEELLKEYGLI 576
COG4716 COG4716
Myosin-crossreactive antigen (function unknown) [Function unknown];
1-591 0e+00

Myosin-crossreactive antigen (function unknown) [Function unknown];


Pssm-ID: 443751  Cd Length: 578  Bit Score: 1096.42  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420   1 MYYSYGNYEAFARPKKPENVENKSAYLIGSGLASLAAACFLIRDGQMEGSKIHILEELPKAGGSLDGENMPLKGYVVRGG 80
Cdd:COG4716    1 MYYSNGNYEAFARPRKPEGVDDKSAYLVGSGLASLAAAAFLIRDGQMPGENIHILEELDLPGGSLDGAGDPEKGYVIRGG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420  81 REMENHFECLWDLFRSIPSLEIDHASVLDEFYWLNKEDPNYSRCRVIEKQGQRLvTDGDFTLTKTAIKEILDLCLTNEED 160
Cdd:COG4716   81 REMENHFECLWDLFRSIPSLEDPGASVLDEFYWLNKDDPNYSKARLIHNQGEIL-DDGKFGLSKKARLEILKLFLTPEED 159
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 161 LDDVKITDVFSDDFFNSNFWIYWKTMFAFEPWHSAMEMRRYLMRFVHHIGGLADFSALKFTKYNQYESLVLPMVEYLKSH 240
Cdd:COG4716  160 LDDKTIEDVFSEEFFESNFWLYWRTMFAFENWHSALEMKRYLHRFIHHIGGLPDLSALKFTKYNQYDSLVLPLVRWLKDH 239
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 241 GVQFEYDVKVEDIKVDVTTSQKIAREILIDRNGNAESIKLTINDLVFVTNGSITESSTYGDNDTPAP-PTDELGGSWTLW 319
Cdd:COG4716  240 GVDFQYGTKVTDVDFDISGGKKTATAIHLERDGKEETIDLTENDLVFVTNGSMTESSTYGDMDTPAPlNTDGPGGSWELW 319
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 320 KNLARQSPEFGNPDKFCQNIPKKSWfVSATSTTNNKDIIDTIESICKRDPLAGKTVTGGIITINDSAWQISFTINRQQQF 399
Cdd:COG4716  320 KNIAAKDPEFGRPEKFCGNIEESNW-ESATVTTLDDKILPYIEKITGRDPYSGKVVTGGIVTFKDSNWLLSWTVNRQPHF 398
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 400 KDQPKNEISTWIYALYSDVNGNYIKKPITECSGNEICQEWLYHLGVPtDKIEDLAKHASNTIPVYMPYITSYFMTRAIGD 479
Cdd:COG4716  399 KNQPDDVLVVWGYGLFSDKPGNYVKKPMRECTGEEILTELLYHLGVP-DQIEELAANSANTIPCMMPYITAQFMPRAAGD 477
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420 480 RPLVVPHQSQNLAFIGNFAETERDTVFTTEYSVRTAMEAVYQLLNIDRGIPEVINSTFDLRVLMDAVYELNDHQDLREIT 559
Cdd:COG4716  478 RPLVVPEGSVNLAFIGQFAETPRDTVFTTEYSVRTAMEAVYTLLGVDRGVPEVFPSQYDIRVLLKATYALNDGKKLPGEG 557
                        570       580       590
                 ....*....|....*....|....*....|..
gi 616688420 560 KdskmqklalagFLKKIKGTYIESLLKEHKLL 591
Cdd:COG4716  558 L-----------LLKKLKGTYIEELLKEYKLI 578
MCRA pfam06100
MCRA family; The MCRA (myosin-cross-reactive antigen) family of proteins were thought to have ...
23-520 0e+00

MCRA family; The MCRA (myosin-cross-reactive antigen) family of proteins were thought to have structural features in common with the beta chain of the class II antigens, as well as myosin, and may play an important role in the pathogenesis. More recent work shows that these proteins act as hydratase enzymes that convert linoleic acid and oleic acid to their respective 10-hydroxy derivatives. It has been suggested that MCRA proteins catalyze the first step in conjugated linoleic acid production. Proteins in this family act in an FAD dependent manner. The structure of a fatty acid double-bond hydratase from Lactobacillus acidophilus has been recently solved showing four structural domains.


Pssm-ID: 428767  Cd Length: 492  Bit Score: 901.07  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420   23 KSAYLIGSGLASLAAACFLIRDGQMEGSKIHILEELPKAGGSLDGENMPLKGYVVRGGREMENHFECLWDLFRSIPSLEI 102
Cdd:pfam06100   1 KKAYIVGSGIASLAAAVFLIRDAQMPGENIHILEELDVAGGSLDGAGDPEKGYVIRGGREMEFHYECLWDLLSSIPSLED 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420  103 DHASVLDEFYWLNKEDPNYSRCRVIEKQGQRLVTDGDFTLTKTAIKEILDLCLTNEEDLDDVKITDVFSDDFFNSNFWIY 182
Cdd:pfam06100  81 PGASVLDEIYWFNKRDPNYSKTRLIDNRGLEIVDDSKLGLSKKDRLELIKLFLTPEEELGDKRIEDVFSPSFFETNFWLM 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420  183 WKTMFAFEPWHSAMEMRRYLMRFVHHIGGLADFSALKFTKYNQYESLVLPMVEYLKSHGVQFEYDVKVEDIKVDVTTSQK 262
Cdd:pfam06100 161 WSTMFAFQPWHSAVEFRRYLHRFIHEIPGLNDLSGLDRTKYNQYESIILPLVKYLKDQGVDFRFNTKVTDIDFDPTGDKK 240
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420  263 IAREILIDRNGNAESIKLTINDLVFVTNGSITESSTYGDNDTPAPP-TDELGGSWTLWKNLARQSPEFGNPDKFCQNIPK 341
Cdd:pfam06100 241 TVTGIHLTQDGEEETIDLGPDDLVFVTNGSMTEGSSYGDNDTPPPLnTDELGGSWSLWKKLAAKSPDFGNPEKFCTDIPE 320
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420  342 KSWfVSATSTTNNKDIIDTIESICKRDPLagktvTGGIITINDSAWQISFTINRQQQFKDQPKNEISTWIYALYSDVNGN 421
Cdd:pfam06100 321 SKW-ESFTVTTKDPKFFDYIEKLTGNDPG-----TGGLVTFKDSNWLLSITVPRQPHFPDQPEDVTVFWGYGLFPDKEGD 394
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420  422 YIKKPITECSGNEICQEWLYHLGVPTDKIEDLAKHaSNTIPVYMPYITSYFMTRAIGDRPLVVPHQSQNLAFIGNFAETE 501
Cdd:pfam06100 395 YVKKPMLECTGEEILTELLYHLGFPEDQIEEILAN-SNTIPCMMPYITAQFMPRAKGDRPEVVPEGSTNLAFIGQFVEIP 473
                         490
                  ....*....|....*....
gi 616688420  502 RDTVFTTEYSVRTAMEAVY 520
Cdd:pfam06100 474 RDTVFTVEYSVRTAQEAVY 492
NAD_binding_8 pfam13450
NAD(P)-binding Rossmann-like domain;
28-95 2.47e-03

NAD(P)-binding Rossmann-like domain;


Pssm-ID: 433218 [Multi-domain]  Cd Length: 67  Bit Score: 36.74  E-value: 2.47e-03
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 616688420   28 IGSGLASLAAACFLirdgQMEGSKIHILEELPKAGGSLDGENMPlkGYVVRGG--REMENHFECLWDLFR 95
Cdd:pfam13450   2 VGAGLAGLVAAALL----AKRGFRVLVLEKRDRLGGNAYSYRVP--GYVFDYGahIFHGSDEPNVRDLLD 65
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH